United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55289-959_3892af8e-2138-00ac-e063-6394a90a516f
- Product NDC
- 55289-959
- Form
- TABLET
- Composition / generic term
- Gabapentin
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060401
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (55289-959-30) · 55289-959-30
- 60 TABLET in 1 BOTTLE, PLASTIC (55289-959-60) · 55289-959-60
- 90 TABLET in 1 BOTTLE, PLASTIC (55289-959-90) · 55289-959-90
- 120 TABLET in 1 BOTTLE, PLASTIC (55289-959-98) · 55289-959-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →